Skip to main content
SNWV
NASDAQ Industrial Applications And Services

SANUWAVE Q3 Revenue Falls 24% to $8.6M; CMS Cuts 2027 Ultramist Reimbursement 21%

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$1.88
Mkt Cap
$16.172M
52W Low
$1.75
52W High
$36.2
52W Position info
7.4% above low
Off High info
95% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

SNWV is trading near its 52-week low of $1.75 (7.4% above the low).

Summary

SANUWAVE's Q3 revenue fell 24% to $8.6 million and it swung to a $1.4 million net loss, while the 2027 CMS final rule cuts the Medicare rate for its Ultramist treatment code by about 21%. Cash is down to $6.6 million against $17.3 million of term loan debt.


Key Events · Earnings and Guidance · SNWV

  • Q3 Revenue Falls 24%

    Revenue was $8.6 million versus $11.3 million a year earlier. Ultramist system revenue dropped 73% to $1.2 million on a 74% decline in unit volume, partly offset by applicator revenue up 2% to $6.9 million.

  • Swing to $1.4M Net Loss

    Net loss of $1.4 million compared with $9.7 million of net income in Q3 2025, which had included a $6.1 million non-cash warrant fair-value gain and a $5.0 million one-time patent payment that did not recur.

  • CMS Cuts 2027 Ultramist Rate 21%

    The 2027 Physician Fee Schedule final rule sets Medicare payment for CPT 97610 at $314.54 per treatment versus $397.81 in 2026, and the company expects a further significant reduction at full phase-in in 2028.

  • Cash Down to $6.6M

    Cash and equivalents fell from $11.959 million at December 31, 2025 to $6.6 million, with $17.3 million outstanding under the Term Loan and $0.7 million drawn on the Revolver; nine-month operating cash flow was a $29 thousand outflow.


Analysis · SNWV · Industrial Applications And Services

The quarter's headline is a 24% revenue decline to $8.6 million, driven by a collapse in Ultramist system sales — down 73% to $1.2 million on a 74% unit volume decline. That pushed the company to a $1.4 million net loss from $9.7 million of net income a year earlier, a comparison inflated by a $6.1 million non-cash warrant gain and a $5.0 million one-time patent payment that did not recur. Cash fell to $6.6 million from $11.959 million at year-end, while $17.3 million of term loan debt amortizes $1.4 million a quarter. Layered on top, the CMS 2027 final rule cuts the Medicare rate for CPT 97610 — the code covering Ultramist treatments — to $314.54 from $397.81, a roughly 21% reduction, with a further decline expected at full phase-in in 2028. That directly pressures the applicator consumable revenue that has been the one growing line, and it comes with a Nasdaq MVLS delisting notice already outstanding and a covenant waiver already needed from JPMorgan.

How filings like this one have moved

In the 30 days to Nov 10, 2026, 47.7% of the 1624 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.19%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, SNWV was trading at $1.88 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $16.2M. The 52-week trading range was $1.75 to $36.20. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SNWV - Latest Insights

SNWV
Nov 05, 2026, 9:08 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $5.71
Real-time Price: $1.88 info
Change: -$3.83 (-67%) info
Market Cap: $16.172M info
SNWV
Oct 28, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $5.27
Real-time Price: $1.88 info
Change: -$3.39 (-64%) info
Market Cap: $16.172M info
SNWV
Sep 25, 2026, 4:38 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $5.04
Real-time Price: $1.88 info
Change: -$3.16 (-63%) info
Market Cap: $16.172M info
SNWV
Aug 06, 2026, 5:07 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $6.01
Real-time Price: $1.88 info
Change: -$4.13 (-69%) info
Market Cap: $16.172M info
SNWV
Aug 06, 2026, 5:00 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $6.00
Real-time Price: $1.88 info
Change: -$4.12 (-69%) info
Market Cap: $16.172M info